CClinicalTrials.gg
CompletedNCT04237285Updated Jan 27, 2020

Effectiveness of Inhalation Aromatherapy In Children With Burns

An interventional study of Inhalation aromatherapy in Burns, sponsored by Izmir Katip Celebi University. Completed at 1 site in Turkey. Open to participants aged 2 Months to 7 Years. Per ClinicalTrials.gov, last updated 2020-01-27.

Sponsored by Izmir Katip Celebi University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled May 2018, registered Jan 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
2 Months to 7 Years
Sex
All
01

Study summary

The study was carried out in the Pediatric Burn Unit, aged between 2 months and 7 years, with no chronic pain, second degree superficial scald burns, hydrotherapy application, no burn surgery, no pathogen growth in the burn site, the burn had not undergone epithelialization. Children receiving routine analgesic therapy were included.

Lavender oil 15 minutes, Lavender oil 60 minutes and Jojoba oil 15 minutes (Placebo group) were studied with a total of 108 children in three groups.

The children included in the study were randomized. One of the researchers measured the pain and vital signs of children before the application. 0.5 cc of aromatherapy oil, which was dripped into the gauze 15 or 60 minutes before the start of hydrotherapy and dressing, was placed 20 cm away from the child's nose. The child who inhaled the smell was hydrotherapy and dressing and then taken to bed. The other investigator, who did not know how long the child inhaled in the morning, evaluated pain and vital signs 1 and 30 minutes after the child returned to bed.

Read the detailed description

This randomized clinical trial research experimental design was performed with pediatric burn patients on May 2018-May 2019. Routine treatment of any child was not interfered with during the data collection phase of the study.

Sample

The minimum sample size in each intervention and control group was considered 36 using G power formula with a = 0.05, power of 80%, 95% confidence interval (Gpower 3.1.9.2., Germany). Allocation to the groups was performed using the Stratified Randomization. The absence of differences in age, vital signs and pain levels between groups prior to the intervention was achieved using Stratified Randomization method.

Intervention Protocols

In the clinic where the study was conducted, all children are routinely given hydrotherapy treatment for the examination of the burn area as of 10 am every morning and then dressings are applied.

Besides routine care, the Control Group was treated with jojoba oil (Simmondsia Chinensis- produced by Arifoğlu, obtained from jojoba fruits by cold squeezing method) inhalation aromatherapy 15 minutes before Hydrotherapy. Jojoba oil was used as a placebo because it had no specific odour. Besides routine care, Intervention-15 Group received lavender oil (Lavandula angustifolia Miller Oleum-produced by Arifoğlu, obtained from lavender flowers by water vapour distillation method) inhalation aromatherapy 15 minutes before Hydrotherapy and besides routine care, Intervention-60 Group received lavender oil inhalation aromatherapy 60 minutes before Hydrotherapy. 0.5 ml (8.44 minim-imperial) of aromatherapy oil, which had been dripped into 7.5x7.5 cm gauze 15 or 60 minutes before the start of Hydrotherapy, was placed 20 cm (7.87 inches) away from the child's nose by the clinical nurse. To conceal the allocation, the group in which the child belongs is only known to the clinical nurse who has placed the aromatherapy oil-soaked gauze in the child's room and this clinical nurse did not carry out any assessment of the child's outcomes.

Data Collection

Before randomization, the characteristics of all participants were collected using the Turkish version of the FLACC Pain Scale, Demographic Data Collection Form, and the Vital Signs Follow-up Form which were developed by the researchers.

By the clinical nurse 0.5 ccs of aromatherapy oil, which had dripped into the gauze, was placed 20 cm away from the child's nose. The child who inhaled the oil was then taken to hydrotherapy and then dressing. The pain and vital signs of the child were evaluated and recorded 1 minute and 30 minutes after the child returned to bed by a researcher who was blind to the study groups.

02

Conditions studied

  • Burns

Browse trials for

Keywords

  • pediatric
  • aromatherapy
03

In context

Burns

719 studies on the registry are indexed under Burns; 145 are open to participants now.

This study's enrollment of 108 is above the median of 40 across 524 interventional studies indexed under Burns.

Browse Burns studies →

Lead sponsor

Izmir Katip Celebi University is the lead sponsor of 191 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Months to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • aged 2 months-7 years,
  • having a second degree of superficial burn,
  • willing to participate in the study,
  • receiving hydrotherapy application (wet dressing),
  • dressing the child with the same dressing material,
  • having no chronic pain,
  • having scalding burn,
  • having no surgery record to treat burns,
  • having no pathogen reproduction at the burn area,
  • having no stage of epitheliazation,
  • having analgesic therapy containing the same active substance.

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
108 participants (actual)

Study arms

  • Experimental
    Lavender 15

    Participant who inhalates lavender oil for 15 minutes.

    Other: Inhalation aromatherapy

  • Experimental
    Lavender 60

    Participant who inhalates lavender oil for 60 minutes.

    Other: Inhalation aromatherapy

  • Placebo comparator
    Jojoba

    Participant who inhalates jojoba oil for 15 minutes.

    Other: Inhalation aromatherapy

Interventions

  • OtherInhalation aromatherapy

    Besides routine care, the Control Group was treated with jojoba oil (Simmondsia Chinensis- produced by Arifoğlu, obtained from jojoba fruits by cold squeezing method) inhalation aromatherapy 15 minutes before Hydrotherapy. Jojoba oil was used as a placebo because it had no specific odor. Besides routine care Intervention-15 Group received lavender oil (Lavandula angustifolia Miller Oleum-produced by Arifoğlu, obtained from lavender flowers by water vapor distillation method) inhalation aromatherapy 15 minutes before Hydrotherapy and besides routine care Intervention-60 Group received lavender oil inhalation aromatherapy 60 minutes before Hydrotherapy.

06

What researchers measure

Primary outcomes

  1. mean arterial pressure

    The mean arterial pressure of the child was evaluated and recorded before dressing, also 1 and 30 minutes after the dressing.

    Time frame: 1 day

  2. body temperature

    The body temperature of the child was evaluated and recorded before dressing, also 1 minute and 30 minutes after the dressing.

    Time frame: 1 day

  3. heart rate

    The heart rate of the child was evaluated and recorded before dressing, also 1 minute and 30 minutes after the dressing.

    Time frame: 1 day

  4. respiratory rate

    The respiratory rate of the child was evaluated and recorded before dressing, also 1 minute and 30 minutes after the dressing.

    Time frame: 1 day

  5. FLACC Pain Scale Scores

    The FLACC Pain Scale scores of the child was evaluated and recorded before dressing, also 1 minute and 30 minutes after the dressing. FLACC (The Face, Legs, Activity, Cry, Consolability Scale) Pain Scale used by Merkel et al in 1997 in children between 2 months-7 years of age. With this scale, five behavioral criteria such as facial expression, the position of legs, movements, crying and comforting are evaluated. Each episode is rated 0-2 with scores ranging from 0-10 in total, the lower the score, the less pain is said .0 points:" no pain "1-3 points:" there is little pain "4-6 points:" there is moderate pain " 7-10 points:" there is much pain".

    Time frame: 1 day

07

Study locations

1 site
  • Dr. Behcet Uz Children's Hospital
    İzmir, 35640, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04237285
Lead sponsor
Izmir Katip Celebi University
Collaborators
Dr. Behcet Uz Children's Hospital
Responsible party
ESRA ARDAHAN AKGUL (Research Assistant, Izmir Katip Celebi University) — Principal investigator
First posted
Jan 23, 2020
Start date
May 1, 2018
Primary completion
May 1, 2019
Completion
Sep 1, 2019
Last update
Jan 27, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion